Inactive Instrument

News HemaCare Corporation OTC Bulletin Board

Stocks

Healthcare Facilities & Services

All News

20-06-02	HemaCare Corporation Adds GMPrime Cryopreserved Leukopak to its GMP Product Portfolio	CI
20-01-21	MicroMedicine and HemaCare Announces Cooperative Efforts to Improve Cell Therapy Starting Materials	CI
20-01-02	Charles River Laboratories International, Inc. completed the acquisition of HemaCare Corporation.	CI
19-12-16	HEMACARE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of HEMA and Encourages Investors to Contact the Firm	PR
19-12-15	Charles River Laboratories International, Inc. entered into a definitive agreement to acquire HemaCare Corporation for approximately $380 million.	CI
19-11-19	HemaCare Expands Its Product Portfolio with GMPrime™ Bone Marrow Aspirate	CI
19-08-27	HemaCare Corporation and Vital River Partner to Provide Human-Derived Biological Material to China	CI
19-08-20	Hemacare Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	CI
19-03-26	HemaCare Corporation Reports Earnings Results for the Year Ended December 31, 2018	CI
18-12-19	HemaCare Corporation announced that it has received $4.999999 million in funding from OBF Investments LLP	CI
18-12-06	HemaCare Corporation Moves its Global Headquarters to Northridge, California	CI
18-11-14	HemaCare Corporation Provides Starting Material for Three FDA Approved Cellular Therapies	CI
18-08-21	HemaCare Corporation Reports Unaudited Earnings Results for the Six Months Ended June 30, 2018	CI
18-07-17	HemaCare Corporation Announces Executive Appointments	CI
18-03-08	HemaCare Corporation Reports Earnings Results for the Full Year Ended December 31, 2017	CI
18-02-06	HemaCare Corporation and Charles River Laboratories International Inc. Announces Strategic Partnership to Accelerate Drug Discovery and Development	CI
17-08-21	HemaCare Corporation Reports Unaudited Earnings Results for the First Six Months Ended June 30, 2017	CI
17-07-24	HemaCare Signs Long Term Lease for Facility Relocation and Expansion	CI
17-03-13	HemaCare Corporation Reports Financial Results for the Year Ended December 31, 2016	CI
17-02-20	HemaCare Corporation Signs Distribution Agreement with Almog Diagnostic	CI
17-01-05	HemaCare Corporation announced that it expects to receive $5 million in funding from OBF Investments LLP	CI
16-10-31	HemaCare Signs Distribution Agreement with Accuresearch Korea, Inc	CI
16-09-06	HemaCare Corp. Reports Unaudited Earnings Results for the First Six Months Ended June 30, 2016	CI
16-05-12	HemaCare Corporation Signs Strategic Distribution Agreement with MT-Biological Science and Technology Co. Ltd	CI
16-03-28	HemaCare Corp. Expands its Offering of Stem Cell-Enriched Peripheral Blood	CI